Tubastatin A, an HDAC6 inhibitor, has been shown to enhance the immune response to M. tuberculosis by decreasing IL-10 levels and increasing TNF-α levels, and increasing the influx of immune cells to the site of infection [263]. The gene discussed is IL10; the disease is infection.